Jason V. Cristofaro, J.D., Ph.D.
Dr. Cristofaro joined the Division of Cancer Treatment and Diagnosis (DCTD) in 2007. During his tenure, Dr. Cristofaro’s work has focused on implementing intellectual property policy to support DCTD’s core function of advancing the development of novel anticancer therapeutic agents, with a particular focus on enabling innovative public-private partnerships. Major projects have included revising the division’s policy for managing internal Cooperative Research and Development Agreements (CRADAs), developing a consistent standard for determining monetary contributions of CRADA partners, revising and implementing DCTD contractual agreements for screening potential anticancer compounds, revising the Intellectual Property Option of the Cancer Therapy Evaluation Program, and developing and vetting the overall contractual agreement structures for the NCI Experimental Therapeutics program (NExT), the MATCH initiative, and the NCI formulary.
Dr. Cristofaro currently serves as Intellectual Property Program Manager for the DCTD and as Alternate Technology Development Coordinator for the NCI. He is responsible for negotiating partnerships with DCTD from early to clinical development and acting as a resource for the division on agreement and partnership related matters.
Prior to joining DCTD, Dr. Cristofaro served two years as a Presidential Management Fellow where he worked in the NCI Office of Technology Transfer and with the Small Business Innovative Research (SBIR) program. His graduate research was focused on the biochemistry of HIV.
Education
- J.D., Georgetown University, District of Columbia
- Ph.D., University of Maryland, Maryland
- B.S., Lock Haven University, Pennsylvania